129 related articles for article (PubMed ID: 10626752)
1. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
Hirano T; Mori T; Kido M; Toide K; Ohura M; Fujiki H; Orito K; Yoshida K; Ikezono K; Sumida T; Nakayama N; Yabuuchi Y
Fundam Clin Pharmacol; 1999; 13(6):650-5. PubMed ID: 10626752
[TBL] [Abstract][Full Text] [Related]
2. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
Okumura K; Ichihara K; Nagasaka M; Oda N; Tajima K
Eur J Pharmacol; 1993 Apr; 235(1):69-74. PubMed ID: 8519282
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
[TBL] [Abstract][Full Text] [Related]
4. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
Mori T; Takeuchi T; Ohura M; Miyakoda G; Fujiki H; Orito K; Yoshida K; Hirano T; Yamamura Y; Sumida T; Nakaya Y; Satake H; Hata F
Mol Cell Biochem; 1998 Jan; 178(1-2):335-43. PubMed ID: 9546618
[TBL] [Abstract][Full Text] [Related]
5. Effects of (+)-S-12967 and (-)-S-12968, two enantiomers of a new slow-acting 1,4-dihydropyridine, on rat coronary resistance arteries.
Prieto D; Mulvany MJ; Nyborg NC
Eur J Pharmacol; 1993 Jul; 238(1):27-35. PubMed ID: 8405080
[TBL] [Abstract][Full Text] [Related]
6. (+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries.
Prieto D; Mulvany MJ; Nyborg NC
Br J Pharmacol; 1991 Jul; 103(3):1703-8. PubMed ID: 1933134
[TBL] [Abstract][Full Text] [Related]
7. Pranidipine enhances the action of nitric oxide released from endothelial cells.
Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
Nakayama N; Ikezono K; Mori T; Yamashita S; Nakayama S; Tanaka Y; Hosokawa T; Minami Y; Masutani K; Yamamura Y
J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
[TBL] [Abstract][Full Text] [Related]
9. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
[TBL] [Abstract][Full Text] [Related]
10. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective pharmacodynamic action of (+)-S-12967 and (-)-S-12968, isomers of a new slow acting 1,4-dihydropyridine derivative with calcium channel agonistic and antagonistic effects on rat aorta.
Poulsen SH; Nyborg NB; Mikkelsen EO
Pharmacol Toxicol; 1992 Jan; 70(1):19-24. PubMed ID: 1317563
[TBL] [Abstract][Full Text] [Related]
12. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
[TBL] [Abstract][Full Text] [Related]
14. Labedipinedilol-C: a third-generation dihydropyridine-type calcium channel antagonist displaying K+ channel opening, NO-dependent and adrenergic antagonist activities.
Yeh JL; Liou SF; Liang JC; Lee CH; Chiu CC; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2005 Aug; 46(2):130-40. PubMed ID: 16044023
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
16. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
18. Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.
Nishikawa M; Kubo Y; Kido H; Nakayama T; Nakamura N
Gen Pharmacol; 1999 Mar; 32(3):299-305. PubMed ID: 10211583
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4- dihydropy ridine as a Ca2+ channel antagonist.
Gengo P; Su CM; Yousif FB; Triggle DJ
Can J Physiol Pharmacol; 1987 Dec; 65(12):2472-82. PubMed ID: 3449204
[TBL] [Abstract][Full Text] [Related]
20. In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.
Yamada S; Uchida S; Urayama A; Kimura R
Pharmacology; 1999 Oct; 59(4):171-82. PubMed ID: 10474077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
